• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Dicomit adds Kodak to list of OEM resellers

Article

Dicomit adds Kodak to list of OEM resellersDicomit has announced that Eastman Kodak of Rochester, NY, has signed an agreement to resell the Richmond Hill, Ontario-based firm's DICOM Image Manager offering as part of the Access ultrasound

Dicomit adds Kodak to list of OEM resellers

Dicomit has announced that Eastman Kodak of Rochester, NY, has signed an agreement to resell the Richmond Hill, Ontario-based firm's DICOM Image Manager offering as part of the Access ultrasound miniPACS line. Kodak displayed DICOM Image Manager at this year's American Institute of Ultrasound in Medicine meeting in Boston.

In other Dicomit news, the firm has added the ability to retrieve prior studies to DICOM Image Manager. Side-by-side comparison of prior and current studies can now also be made on the ultrasound machine monitor, according to the company. The new features are available on any new Dicomit products and also as a software upgrade for Dicomit's installed base.

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.